Pathological effects of neoadjuvant hormonal therapy help predict progression of prostate cancer after radical prostatectomy

Abstract

Background : It is not clear whether pathological changes following neoadjuvant hormonal therapy (NHT) prior to radical prostatectomy have any value as predictors of progression in prostate cancer.Methods : We conducted a study of 100 patients with prostate cancer who underwent radical prostatectomy following NHT. We used the Japanese general rule as the criterion to assess the biochemical recurrence rate and pathological changes after NHT.Results : In terms of preoperative risk factors, the probability of recurrence was significantly higher for patients with more than 20ng/mL of pretreatment serum prostate-specific antigen (PSA) and/or a Gleason score of 7 or higher for biopsy specimens. We defined these pretreatment findings as highrisk factors. Among 65 patients with high-risk factors, patients with a post-NHT pathological effect of grade 3 according to the Japanese general rule showed no recurrence, whereas patients with a grade 0 had a poor prognosis. Patients with a PSA nadir 0.5ng/mL or less tended to have a better prognosis. Conclusion : Despite preoperative high-risk factors, patients showing good pathological effects after NHT tend to have a favorable prognosis after radical prostatectomy. Therefore; assessment of the pathological effects of NHT using the Japanese general rule as the criterion proved to be useful for the prediction of biochemical recurrence.

A Road Map to Comprehensive Androgen Receptor Axis Targeting for Castration-Resistant Prostate Cancer

“…In studies of neoadjuvant medical castration therapy, the probability of early biochemical recurrence was inversely correlated with the degree of pathologic effect (38) and positively correlated with the residual expression of AR-dependent genes, including PSA, identified as early as 3 months after the initiation of hormonal therapy (39). Therefore, failure to adequately suppress the AR axis (or early reactivation of AR signaling) is associated with inferior clinical outcomes.…”

Effectiveness and adverse effects of hormonal therapy for prostate cancer: Japanese experience and perspective

“…Why is the outcome of primary hormonal therapy so excellent, especially in welldifferentiated prostate cancer? Kitagawa et al 10 analyzed the histological effects of hormonal therapy in specimens from patients treated with radical prostatectomy after neoadjuvant hormonal therapy. They reported that histologically cured or nearly cured patients accounted for more than 40% of the total number.…”

Clinical efficacy of primary combined androgen blockade for Japanese men with clinically localized prostate cancer unsuitable for local definitive treatment: a single institution experience

“…This idea may be supported by the histological examination of resected specimens after neoadjuvant hormonal therapy. Namely, it has been shown that a possible histological cure revealed by apoptic change in malignant cells accounted for 40% of the total cases and that the recurrence-free rate of patients who attained complete apoptosis was 100% [17]. In addition, Labrie et al [18] performed long-term CAB in stage-B and -C patients and discontinued the treatment in those who did not have PSA progression.…”